Suppr超能文献

钠/氢交换体在离体灌注大鼠心脏再灌注损伤中的作用。

Role for the Na+/H+ exchanger in reperfusion stunning in isolated perfused rat heart.

作者信息

du Toit E F, Opie L H

机构信息

Ischemic Heart Disease Research Unit, University of Cape Town, South Africa.

出版信息

J Cardiovasc Pharmacol. 1993 Dec;22(6):877-83. doi: 10.1097/00005344-199312000-00016.

Abstract

We tested the hypothesis that Na+/H+ exchange contributes to reperfusion stunning and arrhythmias. The effects of amiloride, an established inhibitor of Na+/H+ exchange, were compared with those of a new inhibitor (HOE 694). Working hearts, subjected to 20-min global ischemia and reperfused for 30 min, were pretreated (for 5 min before ischemia) or reperfused (initial 2 min) with HOE 694 or amiloride. Pretreatment with 10(-7) M HOE increased recovery of aortic output (AO) after 30-min reperfusion: As a percentage of the preischemic controls, values were 38.5 +/- 3.6% (n = 7) for controls versus 50.6 +/- 3.9% (n = 5) for the treated group (p < 0.05). Pretreatment with HOE (10(-6) M) increased AO recoveries from 38.2 +/- 2.0% (n = 5) to 52.9 +/- 2.7% (n = 5) (p < 0.05). Amiloride (10(-5) M) pretreatment improved AO recoveries from 41.6 +/- 2.7% (n = 6) to 55.8 +/- 4.0% (n = 6) (p < 0.05). Thus, pretreatment by both HOE 694 and amiloride decreased reperfusion stunning. Adding HOE (10(-7) M) only in the reperfusion period increased AO recoveries from 36.4 +/- 1.2% (n = 6) to 62.4 +/- 3.2% (n = 11) (p < 0.002). Amiloride (10(-5) or 10(-3) M) added only during reperfusion did not improve recovery of AO. HOE 694, active in much lower concentrations than amiloride, was the only compound active against stunning when added only during reperfusion. In addition, both compounds inhibited reperfusion arrhythmias when added at reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们验证了钠氢交换参与再灌注损伤及心律失常的假说。将钠氢交换的已知抑制剂氨氯吡咪的作用与一种新型抑制剂(HOE 694)的作用进行了比较。对经历20分钟全心缺血并再灌注30分钟的工作心脏,在缺血前(缺血前5分钟)或再灌注时(最初2分钟)用HOE 694或氨氯吡咪进行预处理。用10⁻⁷M HOE预处理可提高再灌注30分钟后主动脉输出量(AO)的恢复:与缺血前对照相比,对照组的值为38.5±3.6%(n = 7),而治疗组为50.6±3.9%(n = 5)(p < 0.05)。用HOE(10⁻⁶M)预处理使AO恢复率从38.2±2.0%(n = 5)提高到52.9±2.7%(n = 5)(p < 0.05)。氨氯吡咪(10⁻⁵M)预处理使AO恢复率从41.6±2.7%(n = 6)提高到55.8±4.0%(n = 6)(p < 0.05)。因此,HOE 694和氨氯吡咪预处理均可减轻再灌注损伤。仅在再灌注期加入HOE(10⁻⁷M)可使AO恢复率从36.4±1.2%(n = 6)提高到62.4±3.2%(n = 11)(p < 0.002)。仅在再灌注期加入氨氯吡咪(10⁻⁵或10⁻³M)并未改善AO的恢复。HOE 694在比氨氯吡咪低得多的浓度下仍有活性,是仅在再灌注期加入时唯一对损伤有作用的化合物。此外,两种化合物在再灌注时加入均能抑制再灌注心律失常。(摘要截选至250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验